MAPT and Alzheimer disease: With their growing role in clinical care, we believe both amyloid and tau PET would benefit from incorporation of image quantification into clinical interpretations, to enhance diagnostic accuracy, facilitate longitudinal measurements, and optimize the potential of molecular imaging to guide management decisions in AD.